131 related articles for article (PubMed ID: 31172920)
1. Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach.
Chimenti MS; Conigliaro P; Triggianese P; Canofari C; Cedola F; Onali S; Calabrese E; Romeo S; Neri B; De Cristofaro E; Biancone L; Perricone R
Clin Exp Rheumatol; 2019; 37(5):723-730. PubMed ID: 31172920
[TBL] [Abstract][Full Text] [Related]
2. Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients.
Conigliaro P; Chimenti MS; Ascolani M; Triggianese P; Novelli L; Onali S; Lolli E; Calabrese E; Petruzziello C; Pallone F; Perricone R; Biancone L
Autoimmun Rev; 2016 Feb; 15(2):184-90. PubMed ID: 26554932
[TBL] [Abstract][Full Text] [Related]
3. Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study.
Luchetti MM; Benfaremo D; Ciccia F; Bolognini L; Ciferri M; Farinelli A; Rossini M; Mosca P; Triolo G; Gabrielli A
World J Gastroenterol; 2017 Oct; 23(39):7139-7149. PubMed ID: 29093622
[TBL] [Abstract][Full Text] [Related]
4. Enteropathic spondyloarthritis: Results from a large nationwide database analysis.
Picchianti-Diamanti A; Lorenzetti R; Chimenti MS; Luchetti MM; Conigliaro P; Canofari C; Benfaremo D; Bruzzese V; Laganà B; Perricone R;
Autoimmun Rev; 2020 Feb; 19(2):102457. PubMed ID: 31838160
[TBL] [Abstract][Full Text] [Related]
5. Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases.
Fatica M; Monosi B; Conigliaro P; D'Antonio A; Essofi S; Cuccagna E; Bergamini A; Biancone L; Monteleone G; Triggianese P; Calabrese E; Chimenti MS
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296800
[TBL] [Abstract][Full Text] [Related]
6. Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study.
Nikiphorou E; van der Heijde D; Norton S; Landewé RB; Molto A; Dougados M; Van den Bosch FE; Ramiro S
Ann Rheum Dis; 2018 Mar; 77(3):405-411. PubMed ID: 29222349
[TBL] [Abstract][Full Text] [Related]
7. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.
Olivieri I; Cantini F; Castiglione F; Felice C; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Vecchi M; Armuzzi A
Autoimmun Rev; 2014 Aug; 13(8):822-30. PubMed ID: 24726868
[TBL] [Abstract][Full Text] [Related]
8. Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study.
Ossum AM; Palm Ø; Cvancarova M; Solberg IC; Vatn M; Moum B; Høivik ML;
Scand J Gastroenterol; 2018; 53(10-11):1250-1256. PubMed ID: 30353756
[TBL] [Abstract][Full Text] [Related]
9. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Rizzello F; Gionchetti P
J Rheumatol; 2017 Sep; 44(9):1341-1346. PubMed ID: 28412702
[TBL] [Abstract][Full Text] [Related]
10. Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry.
Farisoğulları B; Yardımcı GK; Sarı A; Bilgin E; Bölek EÇ; Duran E; Kılıç L; Akdoğan A; Karadağ Ö; Apraş Bilgen Ş; Ertenli Aİ; Kiraz S; Kalyoncu U
Clin Exp Rheumatol; 2022 Jan; 40(1):112-119. PubMed ID: 33635221
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of spondyloarthritis symptom in inflammatory bowel disease patients: A questionnaire survey.
Kamo K; Shuto T; Haraguchi A
Mod Rheumatol; 2015 May; 25(3):435-7. PubMed ID: 25381725
[TBL] [Abstract][Full Text] [Related]
12. Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up Study.
van Erp SJ; Brakenhoff LK; van Gaalen FA; van den Berg R; Fidder HH; Verspaget HW; Huizinga TW; Veenendaal RA; Wolterbeek R; van der Heijde D; van der Meulen-de Jong AE; Hommes DW
J Crohns Colitis; 2016 Feb; 10(2):166-75. PubMed ID: 26512134
[TBL] [Abstract][Full Text] [Related]
13. Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis.
Luchetti MM; Benfaremo D; Bendia E; Bolognini L; Fava G; Marini F; Di Sario A; Ciferri M; Di Nicola F; Marconi V; Perini L; Manfredi L; Pomponio G; Mosca P; Benedetti A; Gabrielli A
Eur J Intern Med; 2019 Jun; 64():76-84. PubMed ID: 31047747
[TBL] [Abstract][Full Text] [Related]
14. Increased proportion of comorbidities but no deterioration of sexual quality of life during a 5-year follow-up in patients with axial spondyloarthritis in the biologic treatment era.
Berg KH; Rohde G; Pripp A; Prøven A; Pirelli Benestad EE; Østensen M; Haugeberg G
Rheumatology (Oxford); 2021 Sep; 60(9):4112-4120. PubMed ID: 33410472
[TBL] [Abstract][Full Text] [Related]
15. Integrated gastroenterology and rheumatology ambulatory: an innovative approach for enteropathic spondyloarthritis early diagnosis.
Lorenzetti R; Scolieri P; Guarini A; De Marinis F; Zullo A; Hassan C; ; Bruzzese V
Ann Ist Super Sanita; 2019; 55(3):246-248. PubMed ID: 31553317
[TBL] [Abstract][Full Text] [Related]
16. Update on therapeutic management of spondyloarthritis associated with inflammatory bowel disease.
Ben Nessib D; Ferjani H; Maatallah K; Rahmouni S; Kaffel D; Hamdi W
Clin Rheumatol; 2020 Dec; 39(12):3543-3553. PubMed ID: 32424656
[TBL] [Abstract][Full Text] [Related]
17. [Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association].
Protzer U; Duchmann R; Höhler T; Hitzler W; Ewe K; Wanitschke R; Meyer zum Büschenfelde KH; Märker-Hermann E
Med Klin (Munich); 1996 Jun; 91(6):330-5. PubMed ID: 8767304
[TBL] [Abstract][Full Text] [Related]
18. Observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis.
Chimenti MS; Conigliaro P; Polistena B; Triggianese P; D'Antonio A; Neri B; Sena G; Spandonaro F; Biancone L; Perricone R
Musculoskeletal Care; 2020 Dec; 18(4):527-534. PubMed ID: 32815627
[TBL] [Abstract][Full Text] [Related]
19. [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
Marín-Jiménez I; Gisbert JP; Pérez-Calle JL; García-Sánchez V; Tabernero S; García-Vicuña R; Romero C; Juliá B; Vanaclocha F; Cea-Calvo L;
Gastroenterol Hepatol; 2015 Dec; 38(10):569-74. PubMed ID: 25983283
[TBL] [Abstract][Full Text] [Related]
20. Rheumatic manifestations of inflammatory bowel diseases: A study from the Middle East.
Hammoudeh M; Elsayed E; Al-Kaabi S; Sharma M; Elbadri M; Chandra P; Abu Nahia N; Hammoudeh S
J Int Med Res; 2018 Sep; 46(9):3837-3847. PubMed ID: 29961404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
